ASH Clinical News Focus on Trainees & Fellows | Page 2
SEPTEMBER 2016
AMERICAN SOCIETY OF HEMATOLOGY (ASH)
HEADQUARTERS
2021 L Street NW, Suite 900
Washington, DC 20036
www.hematology.org
Tel: 202-776-0544
EDITOR-IN-CHIEF
Mikkael Sekeres, MD, MS
Vice-Chair for Clinical Research
Director, Leukemia Program
Cleveland Clinic, Taussig Cancer Institute
Cleveland, OH
ASSOCIATE EDITORS
Beth Faiman, CNP, PhD
Cleveland Clinic
Cleveland, OH
Alice Ma, MD
University of North Carolina School of Medicine
Chapel Hill, NC
CONTENTS
David Steensma, MD
Dana-Farber Cancer Institute
Boston, MA
Keith Stewart, MBChB, MBA
FEATURES
NEWS YOU CAN USE
PUBLISHER
1 What Can the ASH Trainee
Council Do for You?
4
ASH Award and Programs
for Young Hematologists/
Oncologists
Mayo Clinic
Scottsdale, AZ
American Medical Communications (AMC)
EDITORIAL
MANAGING EDITORS
Ariel Jones-DeMaio, AMC
Karen Learner, ASH
ASSOCIATE MANAGING EDITOR
Kerri Fitzgerald, AMC
ART DIRECTOR
Ari Mihos
ASSISTANT ART DIRECTORS
Charlene DePrizio
John Salesi
DIGITAL PROJECTS MANAGER
Chris Gedikli
The ASH Trainee Council was created to
advocate for the issues and concerns of
hematology/oncology trainees, including
mentorship, publishing, and funding.
ASH Clinical News spoke with Sherif M.
Badawy, MD, MS, MBBCh, the immediate
past chair of the Council, about how the
Trainee Council is helping young doctors.
2
Advice from the Future
We asked innovators and mentors
in hematology and oncology: What
advice would you give to early-career
hematologists?
6
Data Stream
Facts and stats about the health-care
landscape.
8
Career Timelines
Every hematologist trainee, whether MD,
DO, or PhD, should have a plan for career
success. The ASH Trainee Council has
created a general career-development
timeline for trainees.
ADVERTISING
ACCOUNT MANAGER
Nick Luciano
[email protected]
Gene Conselyea
[email protected]
Recruitment advertising orders can be sent to:
DIRECTOR, RECRUITMENT CLASSIFIEDS
Lauren Morgan
[email protected]
Visit us at ashclinicalnews.org
Follow us on Twitter @ASHClinicalNews
©2016 by the American Society of Hematology.
All materials contained in this newsletter are protected
by copyright laws and may not be used, reproduced, or
otherwise exploited in any manner without the express
prior written permission of ASH Clinical News. Any
third-party materials communicated to ASH Clinical
News become its copyrighted property and may be used,
reproduced, or otherwise exploited by ASH Clinical News.
All correspondence for the American Society of Hematology should be sent to: American Society of Hematology,
2021 L Street NW, Suite 900, Washington DC 20036.
Neither the American Society of Hematology nor the publisher is responsible for statements made by any editor or contributor. Statements, editorials, or opinions expressed in ASH Clinical News magazine do not necessarily represent official
policy of the American Society of Hematology unless so stated. No responsibility is assumed by the American Society of
Hematology or the Publisher for any injury or damage to persons or property as a matter of product liability, negligence or
otherwise or from any use or operation of any methods, products, instructions or ideas contained in the material herein.
Although all advertising material published in ASH Clinical News magazine is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement by the American Society
of Hematology or the Publisher of the quality or value of such product or of the claim made of it by its manufacturer.
About the American Society of Hematology
The American Society of Hematology (ASH) is the world’s largest professional society concerned with the causes and
treatments of blood disorders. The mission of the Society is to further the understanding, diagnosis, treatment, and
prevention of disorders affecting the blood, bone marrow, and the immunologic, hemostatic and vascular systems,
by promoting research, clinical care, education, training, and advocacy in hematology.